Cargando…
METTL3-mediated m(6)A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis
Doxorubicin (DOX) resistance in breast cancer (BC) poses a huge challenge for the therapeutic effect on BC. Lnc KCNQ1OT1 play crucial roles in chemotherapy resistance. However, the role and mechanism of lnc KCNQ1OT1 in DOX resistance BC have not been investigated, which merits further exploration. B...
Autores principales: | Zhou, Zhiyang, Cao, Yukun, Yang, Yuan, Wang, Shouman, Chen, Feiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228414/ https://www.ncbi.nlm.nih.gov/pubmed/37243702 http://dx.doi.org/10.1080/15592294.2023.2217033 |
Ejemplares similares
-
Regulation of functional KCNQ1OT1 lncRNA by β-catenin
por: Sunamura, Naohiro, et al.
Publicado: (2016) -
LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases
por: Xia, Fangqi, et al.
Publicado: (2021) -
KCNQ1OT1 polymorphism rs35622507 and methylation status of KCNQ1OT1 promoter influence the drug resistance to L-OHP
por: Zhang, Caihong, et al.
Publicado: (2022) -
KCNQ1OT1 promotes melanoma growth and metastasis
por: Guo, Bingyu, et al.
Publicado: (2018) -
KCNQ1OT1: An Oncogenic Long Noncoding RNA
por: Cagle, Patrice, et al.
Publicado: (2021)